Staff information

PNNL Publications

2024

• Lin H., M. Mohammadhosseini, J. McClatchy, M. Villamor-Paya, S. Jeng, D. Bottomly, and C. Tsai, et al. 2024. "The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1B-mediated AML progression." Blood 143, no. 26:2749-2762. PNNL-SA-185293. doi:10.1182/blood.2023022079
• Pino J.C., J.C. Posso Escobar, S.K. Joshi, M.D. Nestor, J. Moon, J.R. Hansen, and C.M. Hutchinson, et al. 2024. "Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia." Cell Reports Medicine 5, no. 1:Art. No. 101359. PNNL-SA-185276. doi:10.1016/j.xcrm.2023.101359
• Velickovic M., T.L. Fillmore, I.K. Attah, J.C. Posso Escobar, J.C. Pino, R. Zhao, and S.M. Williams, et al. 2024. "Coupling microdroplet-based sample preparation, multiplexed isobaric labeling, and nanoflow peptide fractionation for deep proteome profiling of tissue microenvironment." Analytical Chemistry 96, no. 32:12973 - 12982. PNNL-SA-194410. doi:10.1021/acs.analchem.4c00523

2023

• Gosline S., M. Velickovic, J.C. Pino, L.Z. Day, I.K. Attah, A.C. Swensen, and V.G. Danna, et al. 2023. "Proteome mapping of the human pancreatic islet microenvironment reveals endocrine-exocrine signaling sphere of influence." Molecular & Cellular Proteomics 22, no. 8:Art. No. 100592. PNNL-SA-179489. doi:10.1016/j.mcpro.2023.100592

2022

• Gosline S., C.E. Tognon, M.D. Nestor, S.K. Joshi, R.V. Modak, A. Damnernsawad, and J.C. Posso Escobar, et al. 2022. "Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML." Clinical Proteomics 19. PNNL-SA-163043. doi:10.1186/s12014-022-09367-9
• Swensen A.C., D. Velickovic, S.M. Williams, R.J. Moore, L.Z. Day, S. Niessen, and S. Hennessy, et al. 2022. "Proteomic profiling of intra-islet features reveals substructure-specific protein signatures." Molecular & Cellular Proteomics 21, no. 12:Art. No. 100426. PNNL-ACT-SA-10618. doi:10.1016/j.mcpro.2022.100426